| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.29 | 0.08 |